Compare OC & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OC | TECH |
|---|---|---|
| Founded | 1938 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 9.1B |
| IPO Year | 2006 | 1995 |
| Metric | OC | TECH |
|---|---|---|
| Price | $143.97 | $71.79 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $145.27 | $71.82 |
| AVG Volume (30 Days) | 1.4M | ★ 7.6M |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.61% | 0.62% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | N/A | ★ $1,219,635,000.00 |
| Revenue This Year | N/A | $2.49 |
| Revenue Next Year | $3.72 | $6.40 |
| P/E Ratio | ★ N/A | $88.62 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $97.53 | $43.20 |
| 52 Week High | $159.91 | $72.16 |
| Indicator | OC | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 57.98 | 77.23 |
| Support Level | $115.22 | $70.49 |
| Resistance Level | $159.91 | $72.16 |
| Average True Range (ATR) | 6.44 | 0.40 |
| MACD | -0.72 | -0.25 |
| Stochastic Oscillator | 43.62 | 97.73 |
Owens-Corning Inc is a building products company that offers roofing products and systems, insulation products (hermal and acoustical batts, loose fill insulation, spray foam insulation, wet use chopped strand, etc.), and doors and door systems. The company's reportable segments are: Roofing, Insulation, and Doors. Maximum revenue is generated from the Roofing segment, which manufactures and sells residential roofing shingles, oxidized asphalt materials, roofing components, and composite lumber mainly used in residential construction. This segment also manufactures and sells glass mat and specialty veil materials used in building and construction applications. Geographically, the company generates maximum revenue from the United States, followed by Europe, Asia-Pacific, and other markets.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.